One of the largest private health insurers in the U.S. has gone from considering hybrid PET/CT for cardiac indications “experimental/investigational” to displaying willingness to pay for the modality. 

According to a new SCAI statement, the FDA's recommendation would result in "far-reaching consequences" across multiple specialties. 

The American Medical Association Board of Delegates approved a policy calling on payers to reimburse for the drug regadenoson and not to employ payment policies that push for cardiologists to change the drug they use for pharmacologic stress for one that is considered less safe.

Brian Ghoshhajra, MD, division chief, cardiovascular imaging, Massachusetts General Hospital, explains what specialized training is needed to perform coronary computed tomography angiography (CCTA) as interest rapidly rises in this field. 

Artificial intelligence vendor DiA has emerged as a key third-party provider of AI to larger imaging vendors.

Brian Ghoshhajra, MD, MBA, division chief, cardiovascular imaging, Massachusetts General Hospital and associate professor of radiology, Harvard Medical School, and a board member of the Society of cardiovascular Computed Tomography (SCCT), explains the rapidly expanding interest in cardiac computed tomography (CT) under the new chest pain evaluation guidelines.

Brian Ghoshhajra, MD, MBA, division chief, cardiovascular imaging, Massachusetts General Hospital and associate professor of radiology, Harvard Medical School, explains the impact of the iodine contrast shortage on computed tomography (CT) and cardiac imaging.
 

Randall Thompson, MD, immediate past president of the American Society of Nuclear Cardiology, said the group had issues with the document's elevation of cardiac CT and FFR-CT.